Stifel Cuts Intuitive Surgical (ISRG) Price Target on Growth Concerns
Published on · Source: investing.com
AI Summary
Summarized by AI from the source belowStifel has lowered the price target for Intuitive Surgical (ISRG) due to concerns regarding the company's growth potential. This decision reflects uncertainties in the company's future performance, although specific target figures were not disclosed in the article. Analysts often adjust price targets based on market conditions and company performance, which can influence investor sentiment and trading behavior. For investors, changes in price targets from analysts like Stifel may impact decisions regarding stock positions in Intuitive Surgical.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About Intuitive Surgical Inc. (ISRG)
Intuitive Surgical makes the da Vinci robotic-surgery systems.
The Health Care sector covers pharmaceutical, biotech, device and managed-care companies.
Earlier ISRG news
- PROCEPT BioRobotics (PRCT) Trading at 4.5x Sales Amid Growth
- Medtronic (MDT) Gains FDA Approval for New Robotic Surgery Platform
- Intuitive Surgical (ISRG) Trading at $483.46 with P/E Ratios of 59.99 and 47.39
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
